Intelligence · Clinical Development
Pipeline search results
Programs matching “placebo” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 588 pipeline programs matching "placebo" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Placebo capsules
BRIGHT MINDS BIOSCIENCES INC.
Pain Threshold
1 trial -
Placebo de macitentan 10 mg, MACITENTAN
Pari Pharma GmbH
Inoperable Chronic thromboembolic pulmonary hyperTension, Pneumology
1 trial -
Placebo for ABBV-142
AbbVie Deutschland GmbH & Co. KG
Idiopathic Pulmonary Fibrosis
1 trial -
Placebo for ACP-204 capsules
Lacuna Pharma Pty Ltd
Lewy Body Dementia Psychosis (LBDP)
1 trial -
Placebo for AMG 133, AMG 133
Amgen
Type 2 Diabetes Mellitus
1 trial -
Placebo for AMG 451, Rocatinlimab
Amgen
Moderate-to-severe Asthma
1 trial -
Placebo for AZD4144, AZD4144
AstraZeneca AB
Sepsis-associated acute kidney injury (AKI)
1 trial -
Placebo for AZD5148, AZD5148
AstraZeneca AB
Recurrence of Clostridioides difficile Infection
1 trial -
Placebo for GSK5784283.
GlaxoSmithKline
Asthma
1 trial -
Placebo for JNJ-95597528, JNJ-95597528
Janssen-Cilag International N.V.
Moderate to Severe Atopic Dermatitis
1 trial -
Placebo for KER-012, cibotercept
Keros Therapeutics
Pulmonary Arterial Hypertension
1 trial -
Placebo for LAD603, LAD603
Almirall, S.A.
Alopecia areata
1 trial -
Placebo for MK-7240, tulisokibart
Merck Sharp and Dohme
Radiographic axial spondyloarthritis (as known as ankylosing spondylitis)
1 trial -
Placebo for ML-007C-MA bilayer tablet
MapLight Therapeutics
Hallucinations and Delusions Associated with Alzheimer’s Disease Psychosis
1 trial -
Placebo for SPT-300
Seaport Therapeutics
Major Depressive Disorder (MDD), with or without Anxious Distress
1 trial -
Placebo for bms-986435-01
Bristol-Myers Squibb Australia Pty Ltd
Heart failure with preserved ejection fraction (HFpEF)
1 trial -
Placebo matching BI 764198, BI 764198
Boehringer Ingelheim
Proteinuric kidney diseases
1 trial -
Placebo of IPN10200, IPN10200
Ipsen
Cervical Dystonia
1 trial -
Placebo of NAL, NACYSTELYN
Laboratoire HRA Pharma
Obstructive Sleep Apnea
1 trial -
Placebo oral capsule
United Therapeutics Europe Ltd
Osteoarthritis, Knee
1 trial -
Placebo session 1, Aprepitant session 2
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Dependence
1 trial -
Placebo to AVTX-009, AVTX-009
Avalo Therapeutics
Hidradenitis suppurativa (HS)
1 trial -
Placebo to BAY 3401016, BAY 3401016
Bayer AG
Alport Syndrome, Chronic kidney disease
1 trial -
Placebo to BI 765423, BI 765423
Boehringer Ingelheim
Idiopathic Pulmonary Fibrosis (IPF)
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.